2022 Q2 Form 10-Q Financial Statement

#000165495422006967 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $636.6K $87.20K $26.40K
YoY Change 213.62%
Cost Of Revenue $319.0K $41.08K $9.790K
YoY Change 358.89% 3188.87%
Gross Profit $317.7K $46.12K $16.61K
YoY Change 137.98% 5189.22%
Gross Profit Margin 49.9% 52.89% 62.92%
Selling, General & Admin $627.1K $551.7K $178.2K
YoY Change -27.08% 5.5% -59.5%
% of Gross Profit 197.41% 1196.24% 1072.79%
Research & Development $1.635M $1.577M $1.274M
YoY Change
% of Gross Profit 514.65% 3420.18% 7669.18%
Depreciation & Amortization $1.210M $1.169M
YoY Change 135.03%
% of Gross Profit 380.93% 2534.08%
Operating Expenses $2.262M $2.129M $1.452M
YoY Change -363.01% 307.12% 230.01%
Operating Profit -$1.944M -$2.083M -$1.435M
YoY Change 167.61% 298.97% 226.23%
Interest Expense $3.417K $15.88K -$9.330K
YoY Change 0.0% -258.83% -6.7%
% of Operating Profit
Other Income/Expense, Net $9.060K $146.00 $0.00
YoY Change -101.05%
Pretax Income -$1.954M -$2.100M -$1.445M
YoY Change 160.62% 296.21% 221.06%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.954M -$2.100M -$1.445M
YoY Change 160.62% 293.23% 221.06%
Net Earnings / Revenue -306.94% -2408.14% -5472.61%
Basic Earnings Per Share
Diluted Earnings Per Share -$203.0K -$218.2K -$96.18K
COMMON SHARES
Basic Shares Outstanding 144.4M shares 142.4M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.754M $1.871M $1.752M
YoY Change 189.11% 18613.5% 8657.5%
Cash & Equivalents $1.754M $1.871M $1.751M
Short-Term Investments
Other Short-Term Assets $1.275M $813.9K $466.2K
YoY Change 935.43% 2613.03% 832.4%
Inventory $670.5K $337.8K $183.4K
Prepaid Expenses
Receivables $0.00
Other Receivables
Total Short-Term Assets $3.699M $3.023M $2.218M
YoY Change 325.42% 7457.65% 2802.25%
LONG-TERM ASSETS
Property, Plant & Equipment $1.503M $1.420M $1.188M
YoY Change 6456.84% 36455.92%
Goodwill
YoY Change
Intangibles $37.33M
YoY Change 20566.34%
Long-Term Investments
YoY Change
Other Assets $124.7K $79.60K $87.57K
YoY Change 61.67%
Total Long-Term Assets $36.71M $37.71M $38.60M
YoY Change 85.87% 20851.78% 20894.72%
TOTAL ASSETS
Total Short-Term Assets $3.699M $3.023M $2.218M
Total Long-Term Assets $36.71M $37.71M $38.60M
Total Assets $40.41M $40.74M $40.82M
YoY Change 95.97% 18416.48% 15583.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $109.1K $1.005M
YoY Change 569.91%
Accrued Expenses $2.598M $1.340M $28.67K
YoY Change 12532.33% 282.74% 18.5%
Deferred Revenue
YoY Change
Short-Term Debt $1.013M $1.013M $3.590M
YoY Change -40.79% 322.25% 277.89%
Long-Term Debt Due $3.377M $3.377M $3.380M
YoY Change 120.69% 267.01%
Total Short-Term Liabilities $6.988M $5.730M $30.59M
YoY Change 194.1% 281.97% 2684.97%
LONG-TERM LIABILITIES
Long-Term Debt $27.40M $26.90M $0.00
YoY Change
Other Long-Term Liabilities $18.32K $24.15K $30.26K
YoY Change -54.85%
Total Long-Term Liabilities $27.42M $26.92M $30.26K
YoY Change 67466.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.988M $5.730M $30.59M
Total Long-Term Liabilities $27.42M $26.92M $30.26K
Total Liabilities $34.41M $32.65M $30.63M
YoY Change 1323.64% 2076.91% 2687.72%
SHAREHOLDERS EQUITY
Retained Earnings -$14.16M -$12.21M -$10.11M
YoY Change 88.74% 62.52%
Common Stock $1.444M $1.444M
YoY Change 1.48% 243.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.006M -$8.083M $10.20M
YoY Change
Total Liabilities & Shareholders Equity $40.41M $40.74M $40.82M
YoY Change 95.97% 18416.48% 15583.34%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income -$1.954M -$2.100M -$1.445M
YoY Change 160.62% 293.23% 221.06%
Depreciation, Depletion And Amortization $1.210M $1.169M
YoY Change 135.03%
Cash From Operating Activities -$229.3K -$1.390M -$680.8K
YoY Change 434.03% 556.42% 656.48%
INVESTING ACTIVITIES
Capital Expenditures -$424.6K $135.9K -$143.8K
YoY Change 1721.36% -1537.9%
Acquisitions
YoY Change
Other Investing Activities $135.9K -$135.9K $6.610K
YoY Change 339650.0%
Cash From Investing Activities -$288.7K -$135.9K -$137.2K
YoY Change 1139.95% 1271.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 545.0K $1.645M 1.864M
YoY Change -16.23% 727.12% 6114.13%
NET CHANGE
Cash From Operating Activities -229.3K -$1.390M -680.8K
Cash From Investing Activities -288.7K -$135.9K -137.2K
Cash From Financing Activities 545.0K $1.645M 1.864M
Net Change In Cash 27.08K $119.1K 1.046M
YoY Change -95.37% -1025.52% -1594.61%
FREE CASH FLOW
Cash From Operating Activities -$229.3K -$1.390M -$680.8K
Capital Expenditures -$424.6K $135.9K -$143.8K
Free Cash Flow $195.3K -$1.526M -$537.0K
YoY Change -1095.41% 437.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
144379308 shares
CY2022Q1 us-gaap Notes Payable
NotesPayable
1013405 USD
CY2021Q4 us-gaap Notes Payable
NotesPayable
213405 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1443793 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q1 aimd Convertible Notes Payable Noncurrent
ConvertibleNotesPayableNoncurrent
26900000 USD
CY2021Q4 aimd Convertible Notes Payable Noncurrent
ConvertibleNotesPayableNoncurrent
0 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24152 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
30255 USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
144379308 shares
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18899873 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18856430 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12208811 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10108916 USD
CY2022Q1 aimd Translation Adjustment Liability
TranslationAdjustmentLiability
-52259 USD
CY2021Q4 aimd Translation Adjustment Liability
TranslationAdjustmentLiability
5800 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
8082596 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10197107 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40736264 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40822161 USD
CY2022Q1 us-gaap Revenues
Revenues
87200 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
551730 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
2129184 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
522981 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2083062 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-522109 USD
CY2022Q1 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-16687 USD
CY2021Q1 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-11897 USD
CY2022Q1 us-gaap Other Expenses
OtherExpenses
146 USD
CY2021Q1 us-gaap Other Expenses
OtherExpenses
0 USD
CY2022Q1 aimd Total Non Operating Income And Expenses
TotalNonOperatingIncomeAndExpenses
-16833 USD
CY2021Q1 aimd Total Non Operating Income And Expenses
TotalNonOperatingIncomeAndExpenses
-11897 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2099895 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-534006 USD
CY2022Q1 aimd Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
CY2021Q1 aimd Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
CY2022Q1 aimd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
144379308 shares
CY2021Q1 aimd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
42066172 shares
CY2022Q1 aimd Net Loss
NetLoss
-2099895 USD
CY2021Q1 aimd Net Loss
NetLoss
-534006 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
58059 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2157954 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-534006 USD
CY2022Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
43443 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2099895 USD
CY2022Q1 aimd Translation Adjustment
TranslationAdjustment
-58059 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
8082596 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-838278 USD
CY2021Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
94105 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-534006 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1278179 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-2099895 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-534006 USD
CY2022Q1 us-gaap Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
1168773 USD
CY2021Q1 us-gaap Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
3905 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
43443 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
94105 USD
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
-337805 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1644884 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
198869 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
119096 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12868 USD
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
754 USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 USD
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
3024 USD
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
297707 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1751499 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22245 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1871349 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9377 USD
CY2022Q1 aimd Issuance Of Convertible Notes For Payables Related Party
IssuanceOfConvertibleNotesForPayablesRelatedParty
26000000 USD
CY2021Q1 aimd Issuance Of Convertible Notes For Payables Related Party
IssuanceOfConvertibleNotesForPayablesRelatedParty
0 USD
CY2022Q1 us-gaap Notes Issued1
NotesIssued1
50000 USD
CY2021Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-18254 USD
CY2022Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
133302 USD
CY2021Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
202981 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1389889 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-211737 USD
CY2022Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
135899 USD
CY2021Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-135899 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2022Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
850000 USD
CY2021Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
236854 USD
CY2022Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
800000 USD
CY2021Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
37985 USD
CY2022Q1 aimd Payments Of Lease Liabilities
PaymentsOfLeaseLiabilities
5116 USD
CY2021Q1 aimd Payments Of Lease Liabilities
PaymentsOfLeaseLiabilities
0 USD
CY2021Q1 us-gaap Notes Issued1
NotesIssued1
0 USD
CY2022Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
202002 USD
CY2021Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
0 USD
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
4389931 USD
CY2021 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
3589931 USD
CY2022Q1 aimd Total Convertible And Nonconvertiblepayment
TotalConvertibleAndNonconvertiblepayment
0 USD
CY2021 aimd Non Convertible Notes Payable Related Party
NonConvertibleNotesPayableRelatedParty
129405 USD
CY2022Q1 aimd Non Convertible Notes Payable Related Party Addition
NonConvertibleNotesPayableRelatedPartyAddition
800000 USD
CY2022Q1 aimd Non Convertible Notes Payable Related Party
NonConvertibleNotesPayableRelatedParty
929405 USD
CY2022Q1 aimd Non Convertible Notes Payable Related Party Accrued Interest
NonConvertibleNotesPayableRelatedPartyAccruedInterest
1489 USD
CY2021 aimd Total Non Convertible Notes Payable
TotalNonConvertibleNotesPayable
213405 USD
CY2022Q1 aimd Total Non Convertible Notes Payable Addition
TotalNonConvertibleNotesPayableAddition
800000 USD
CY2022Q1 aimd Total Non Convertible Notes Payable
TotalNonConvertibleNotesPayable
1013405 USD
CY2022Q1 aimd Total Non Convertible Notes Payable Accrued Interest
TotalNonConvertibleNotesPayableAccruedInterest
5016 USD
CY2021 aimd Total Convertible And Nonconvertible
TotalConvertibleAndNonconvertible
3589931 USD
CY2022Q1 aimd Total Convertible And Nonconvertibleaddition
TotalConvertibleAndNonconvertibleaddition
800000 USD
CY2022Q1 aimd Total Convertible And Nonconvertible
TotalConvertibleAndNonconvertible
4389931 USD
CY2022Q1 aimd Total Convertible And Nonconvertiblepaymentaccrued
TotalConvertibleAndNonconvertiblepaymentaccrued
44556 USD
CY2022Q1 aimd Convertible Notes Amount
ConvertibleNotesAmount
3000000 USD
CY2022Q1 aimd Principal Amount Property
PrincipalAmountProperty
800000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
15883 USD
CY2021 us-gaap Interest Expense
InterestExpense
11897 USD
CY2022Q1 aimd Cumulative Accrued Interest
CumulativeAccruedInterest
44556 USD
CY2021Q4 aimd Cumulative Accrued Interest
CumulativeAccruedInterest
28673 USD
CY2022Q1 aimd Non Current Convertible Notes Payable
NonCurrentConvertibleNotesPayable
26900000 USD
aimd Non Current Convertible Notes Payable
NonCurrentConvertibleNotesPayable
0 USD
CY2022Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
26000000 USD
CY2022Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.01
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
26000000 USD
CY2022Q1 aimd Principal Amount Property
PrincipalAmountProperty
26000000 USD
CY2022Q1 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
4355931 USD
CY2021Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
3505931 USD
CY2022Q1 aimd Covid Ninteen Antigen Rapid Test Kits Amount
CovidNinteenAntigenRapidTestKitsAmount
386412 USD
CY2022Q1 aimd Research And Development Expense1
ResearchAndDevelopmentExpense1
167422 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
109131 USD
CY2022Q1 aimd Convertible Notes Amount
ConvertibleNotesAmount
3000000 USD

Files In Submission

Name View Source Status
0001654954-22-006967-index-headers.html Edgar Link pending
0001654954-22-006967-index.html Edgar Link pending
0001654954-22-006967.txt Edgar Link pending
0001654954-22-006967-xbrl.zip Edgar Link pending
aimd-20220331.xsd Edgar Link pending
aimd-20220331_cal.xml Edgar Link unprocessable
aimd-20220331_def.xml Edgar Link unprocessable
aimd-20220331_lab.xml Edgar Link unprocessable
aimd-20220331_pre.xml Edgar Link unprocessable
aimd_10k.htm Edgar Link pending
aimd_10k_htm.xml Edgar Link completed
aimd_ex241.htm Edgar Link pending
aimd_ex311.htm Edgar Link pending
aimd_ex312.htm Edgar Link pending
aimd_ex321.htm Edgar Link pending
aimd_ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending